| Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment EI Deryugina, E Zajac, A Juncker-Jensen, TA Kupriyanova, L Welter, ... Neoplasia 16 (10), 771-788, 2014 | 275 | 2014 |
| Genomic cfDNA analysis of aqueous humor in retinoblastoma predicts eye salvage: The surrogate tumor biopsy for retinoblastoma JL Berry, L Xu, I Kooi, AL Murphree, RK Prabakar, M Reid, K Stachelek, ... Molecular Cancer Research 16 (11), 1701-1712, 2018 | 88 | 2018 |
| Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patient L Welter, L Xu, D McKinley, AE Dago, RK Prabakar, S Restrepo-Vassalli, ... Molecular Case Studies 6 (6), a005819, 2020 | 29 | 2020 |
| Clonal diversity revealed by morphoproteomic and copy number profiles of single prostate cancer cells at diagnosis PD Malihi, M Morikado, L Welter, ST Liu, ET Miller, RM Cadaneanu, ... Convergent Science Physical Oncology 4 (1), 015003, 2018 | 24 | 2018 |
| Preanalytical variables for the genomic assessment of the cellular and acellular fractions of the liquid biopsy in a cohort of breast cancer patients SN Shishido, L Welter, M Rodriguez-Lee, A Kolatkar, L Xu, C Ruiz, ... The Journal of Molecular Diagnostics 22 (3), 319-337, 2020 | 20 | 2020 |
| A new anion exchange purification method for Cu stable isotopes in blood samples SC Yang, L Welter, A Kolatkar, J Nieva, KR Waitman, KF Huang, WH Liao, ... Analytical and bioanalytical chemistry 411 (3), 765-776, 2019 | 20 | 2019 |
| Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib SN Shishido, R Masson, L Xu, L Welter, RK Prabakar, A D’Souza, ... npj Breast Cancer 8 (1), 1-14, 2022 | 11 | 2022 |
| Circulating Tumor Cell Kinetics and Morphology from the Liquid Biopsy Predict Disease Progression in Patients with Metastatic Colorectal Cancer Following Resection D Kolenčík, S Narayan, JA Thiele, D McKinley, AS Gerdtsson, L Welter, ... Cancers 14 (3), 642, 2022 | 5 | 2022 |
| A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222 HCF Moore, WE Barlow, G Somlo, JR Gralow, AF Schott, DF Hayes, ... Clinical Cancer Research, 2021 | 5 | 2021 |
| Abstract: Genomic cfDNA analysis of aqueous humor in retinoblastoma (RB) predicts eye salvage L Xu, JL Berry, I Kooi, AL Murphree, RK Prabakar, MW Reid, K Stachelek, ... American Association for Cancer Research - Annual Meeting 79 (13 Supplement …, 2019 | 2* | 2019 |
| Serum phosphatidylcholine is lower among breast cancer patients on systemic chemotherapy. X Li, J Lim, A Kolatkar, L Welter, K Waitman, ESS Hwang, JM Lu, P Kuhn, ... Journal of Clinical Oncology 35 (15_suppl), e12571-e12571, 2017 | 2 | 2017 |
| Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics L Welter, S Zheng, SM Setayesh, M Morikado, A Agrawal, R Nevarez, ... Cancers 15 (15), 3949, 2023 | | 2023 |
| Abstract: Morphologic and genomic characterization of circulating tumor cells in patients with ERBB2 mutant HER2 non-amplified metastatic breast cancer treated with neratinib SN Shishido, R Masson, L Welter, L Xu, A D'Souza, D Spicer, J Hicks, ... American Association for Cancer Research - Annual Meeting 79 (13 Supplement …, 2019 | | 2019 |
| Abstract P3-01-09: Tracing clonal evolution of circulating tumor cells and cell-free DNA in a metastatic breast cancer patient L Welter, L Xu, D McKinley, AE Dago, S Restrepo-Vassalli, MR Lee, ... San Antonio Breast Cancer Symposium 79 (4 Supplement), P3-01-09-P3-01-09, 2019 | | 2019 |
| Abstract: Integration of genomic analysis and assessment of pre-analytic variables in the HD-SCA workflow: A technical validation study SN Shishido, M Rodriguez_Lee, A Kolatkar, L Xu, S Restrepo-Vassalli, ... American Association for Cancer Research - Annual Meeting 78 (13 Supplement …, 2018 | | 2018 |
| Abstract: Characterization of disease evolution in sequential sampled metastatic breast cancer using liquid biopsy L Welter, L Xu, D McKinley, S Restrepo-Vassalli, A Dago, MR Lee, ... American Association for Cancer Research - Annual Meeting 78 (13 Supplement …, 2018 | | 2018 |
| Abstract: Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib. A D'souza, S Shishedo, DV Spicer, L Welter, Y Jiang, DM Hyman, DB Solit, ... American Society of Clinical Oncology 35 (15_suppl), e12554-e12554, 2017 | | 2017 |
